Impact of Chronic Pulmonary Aspergillosis (CPA) on Health Status and Well-being

Status: Recruiting
Location: See all (3) locations...
Study Type: Observational
SUMMARY

To develop and validate a novel disease-specific questionnaire for measuring HRQoL in patients with Chronic Pulmonary Aspergillosis (CPA-HAQ) for use in clinical research, including clinical trials.

Eligibility
Participation Requirements
Sex: All
Minimum Age: 18
Healthy Volunteers: f
View:

• All patients \>/= 18 years old and able to provide informed consent

• Patients with a diagnosis of chronic pulmonary aspergillosis

• To speak and understand English

• Able to provide informed consent

Locations
Other Locations
United Kingdom
Ninewells Hospital & Medical School
RECRUITING
Dundee
Imperial College London
RECRUITING
London
Manchester NHS Foundation Trust
RECRUITING
Manchester
Contact Information
Primary
Dareen Marghlani, MSc
dsm20@ic.ac.uk
dsm20@ic.ac.uk
Backup
Anand Shah, PhD
s.anand@imperial.ac.uk
Time Frame
Start Date: 2024-11-27
Estimated Completion Date: 2026-04-23
Participants
Target number of participants: 100
Related Therapeutic Areas
Sponsors
Collaborators: Manchester University NHS Foundation Trust, Tayside Medical Science Centre
Leads: Imperial College London

This content was sourced from clinicaltrials.gov